Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia

Clinical trial NCT00176423 · COMPLETED

Trial details

NCT number: NCT00176423
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2002-05-01
Primary completion: 2006-12-01
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.